Replacing the tuberculin skin test with a specific blood test

Kekkaku

Volumn 80, Issue 8, 2005, Pages 581-585

  Weldingh, Karin ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antigen discovery; Diagnosis; ESAT6; Interferon gamma assay; QuantiFERON TB; RD1 antigens; Tuberculosis

Indexed keywords

BCG VACCINE; CFP10 ANTIGEN; ESAT6 ANTIGEN; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG;

BCG VACCINATION; BLOOD ANALYSIS; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HEMATOLOGIC TESTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDE FRAGMENTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 25144462666     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Haslov K, et al.: Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun. 1995; 63: 804-810.
2. Pollock JM, Andersen P: The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis. 1997; 175: 1251-54.
3. Brock I, et al.: Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis. 2001; 5: 462-467.
4. Cooper AM, et al.: Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993; 178: 2243-47.
5. Flynn JL, et al.: An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993; 178: 2249-54.
6. Dorman SE, et al.: Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004; 364: 2113-21.
7. Orme IM: Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol. 1988; 140: 3589-93.
8. Andersen P, et al.: T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun. 1991; 59: 1558-63.
9. Andersen P, et al.: Proteins released from Mycobacterium tuberculosis during growth. Infect Immun. 1991; 59: 1905-10.
10. Andersen P, Heron I: Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun. 1993; 61: 844-851.
11. Andersen P, Heron I: Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods. 1993; 161: 29-39.
12. Pollock JM, Andersen P: Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun. 1997; 65: 2587-92.
13. Boesen H, et al.: Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun. 1995; 63: 1491-97.
14. Sorensen AL, et al.: Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 1995; 63: 1710-17.
15. Andersen P, et al.: Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154: 3359-72.
16. Ravn P, et al.: Human Tcell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis. 1999; 179: 637-645.
17. Behr MA, et al.: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999; 284: 1520-23.
18. Pym AS, et al.: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002; 46: 709-717.
19. Hsu T, et al.: The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA. 2003; 100: 12420-25.
20. Mori T, et al.: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59-64.
21. Brock I, et al.: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004; 170: 65-69.
22. Ewer K, et al.: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168-73.
23. Aagaard C, et al.: Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J Infect Dis. 2004; 189: 812-819.
24. Okkels LM, et al.: PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family. Infect Immun. 2003; 71: 6116-23.
25. Brock I, et al.: Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol. 2004; 42: 2379-87.
26. Pathan AA, et al.: Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol. 2001; 167: 5217-25.
27. Smith SM, et al.: Human CD8 (+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis sis patients and healthy BCG-vaccinated controls in The Gambia. Infect Immun. 2000; 68: 7144-48.
28. Tesfa L, et al.: Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool. Cytometry. 2004; 60B: 47-53.
29. Ravn P, et al.: Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol. 2005; 12: 491-496.
30. Ferrara G, et al.: Routine Hospital Use of a Commercial Whole Blood Interferon- 7 Assay for Tuberculosis Infection. Am J Respir Crit Care Med. 2005; 172: 631-635.